Alprax 0.25mg 15 Tablets

Babies: Not applicable. Lactating mothers: It is unsafe to use this medicine during breastfeeding. Studies have shown that the drug passes into the breastmilk and causes harm to the baby. Pregnancy: It is unsafe to use this medicine during pregnancy.
Studies have shown that the medicine causes harmful effects on the developing baby. Seek a doctor's advice before taking this medicine. Alcohol: It is unsafe to consume alcohol while taking this medicine. Driving: This medicine may cause dizziness, sleepiness and alters your ability to drive.
Do not drive if you experience these symptoms. Kidney: It is safe to use this medicine in patients with kidney disease.
Dose adjustment is not required. Seek a doctor's advice before taking this medicine. Liver: This medicine should be used with caution in patients with liver diseases.
Studies have shown that dose adjustment is required in these patients. Seek a doctor's advice before using this medicine..

Lightheadedness Dizziness Drowsiness.

Alprax belongs to the class of benzodiazepines used in the treatment of anxiety and panic disorder. It works by increasing the action of a chemical messenger that suppresses the abnormal activity of nerve cells in the brain..

If you miss a dose, take it as soon as possible. If it is near the time of the next dose, then skip the missed dose.
Take the prescribed dose on your regular time daily. Don't double the dose to catch up with the missed dose..

• Take this medicine as prescribed by your doctor. • To get better results to take this medicine at a fixed time regularly. • Finish the entire course of this medicine. • Do not stop taking this medicine too early without consulting your doctor. • If you experience lightheadedness and drowsiness for a longer duration while taking this medicine, inform your doctor..

Major • Alprax + Atazanavir: Concurrent use may lead to an increase in the risk of drowsiness • Alprax + Clarithromycin: Concurrent use may lead to an increase in the risk of motor impairment and excessive drowsiness • Alprax + Fentanyl: Concurrent use may lead to an increase in the risk of respiratory distress • Alprax + Itraconazole: Concurrent use may lead to an increase in the risk of drowsiness • Alprax + Ritonavir: Concurrent use may lead to an increase in the risk of breathing difficulties • Alprax + Pentazocine: Concurrent use may lead to an increase in the risk of respiratory distress Moderate: • Alprax + Amiloride: Concurrent use may lead to an increase in the risk of heart rate • Alprax + Baclofen: Concurrent use may lead to an increase in the risk of dizziness and drowsiness • Alprax + Furosemide: Concurrent use may lead to an increase in the risk of dizziness and headache • Alprax + Imipramine: Concurrent use may lead to an increase in the risk of dizziness and drowsiness.